Since the RAF/MEK/ERK pathway and PI3K/AKT activity are critical in the progression of HCC [23], we analyzed the impact of GCS inhibition with PDMP on these pathways. This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.